Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

Clinical trial NCT00663169 · COMPLETED

Trial details

NCT number: NCT00663169
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Gouty

Start date: 2008-04-01
Primary completion: 2009-10-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.